| Medtronic Discloses Doctor Pay Medtronic voluntarily disclosed that it paid $15.7 million in royalties and consulting fees to U.S. doctors in the first quarter. online.wsj.com |
Pfizer to Withdraw a Cancer Drug The FDA said Pfizer is withdrawing its cancer drug Mylotarg from the U.S. market after a clinical study showed the drug wasn't effective and had more safety problems. online.wsj.com |
Judge Says Watson CEO Should Testify A federal magistrate judge recommended Tuesday that Watson Pharmaceuticals Chief Executive Paul Bisaro be forced to testify in an FTC probe of a patent settlement between the generic drug maker and Cephalon. online.wsj.com |
Big Pharma Looks to Biotech for Innovation The Burrill Report submits: By Marie DaghlianEarly stage deals between pharma and biotech underscore pharma companies’ increasing reliance on biotech as a source of innovation. Both Roche (RHHBY.PK) and Lilly (LLY) have been stung by setbacks in their drug development programs in recent weeks, and both of them announced new alliances to develop novel therapeutics.Complete Story » seekingalpha.com |
Cardinal Health Buys Chinese Firm Cardinal Health is buying privately held Zuellig Pharma China, that country's largest pharmaceutical importer, for $470 million including assumption of debt. online.wsj.com |